Ph. Dijk et al., SURFACTANT NEBULIZATION VERSUS INSTILLATION DURING HIGH-FREQUENCY VENTILATION IN SURFACTANT-DEFICIENT RABBITS, Pediatric research, 44(5), 1998, pp. 699-704
Surfactant nebulization improves lung function at low alveolar doses o
f surfactant. However, efficiency of nebulization is low, and lung dep
osition seems to depend on lung aeration. High frequency ventilation (
HFV) has been shown to improve lung aeration. We hypothesize that the
combination of HFV and surfactant nebulization may benefit lung deposi
tion of surfactant and consequently, lung function. The aim of this st
udy was to compare the effect of surfactant nebulization versus instil
lation during HFV on lung function, surfactant distribution, and cereb
ral blood flow. Therefore, severe respiratory failure was induced by l
ung lavages in 18 rabbits. HFV was applied: frequency = 8 Hz, mean air
way pressure = 12 cm H2O, amplitude = 100%, fraction of inspired O-2 =
1.0. Technetium-99m-labeled surfactant (Alveofact, 100 mg/kg of BW) w
as nebulized or instilled (n = 6 each). Six other rabbits did not rece
ive surfactant (control, HFV only). We found that after instillation p
artial arterial O-2 tension increased from 7.0 kPa (95% confidence int
erval, 6.3-8.0 kPa) to 34 kPa (16-51 kPa), and during nebulization fro
m 7.0 kPa (6.0-9.0 kPa) to 46 kPa (27-58 kPa). Partial arterial CO, te
nsion decreased after instillation from 6.1 kPa (5.3-7.1 kPa) to 4.8 k
Pa (3.9-5.6 kPa), and during nebulization, after an initial rise, it d
ecreased from 6.3 kPa (5.3-7.4 kPa) to 4.9 kPa (4.4-5.6 kPa). Both tre
atments resulted in nonuniform distribution. Surfactant deposition aft
er nebulization was 9.8%, Instillation resulted in a drop of mean arte
rial blood pressure of 17% (8-31%), and an even more pronounced drop i
n cerebral blood flow of 39% (18-57%). Nebulization did not affect blo
od pressure. Cerebral blood flow decreased with a maximum of 27% (10-3
7%). We conclude that surfactant nebulization during HFV improves lung
function in rabbits with severe respiratory failure, without improvin
g distribution, but with less effects on blood pressure and cerebral b
lood flow, when compared with surfactant instillation.